| 000 | 02527 a2200697 4500 | ||
|---|---|---|---|
| 005 | 20250517051044.0 | ||
| 264 | 0 | _c20161017 | |
| 008 | 201610s 0 0 eng d | ||
| 022 | _a1522-9653 | ||
| 024 | 7 |
_a10.1016/j.joca.2015.08.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCharlier, E | |
| 245 | 0 | 0 |
_aRestriction of spontaneous and prednisolone-induced leptin production to dedifferentiated state in human hip OA chondrocytes: role of Smad1 and β-catenin activation. _h[electronic resource] |
| 260 |
_bOsteoarthritis and cartilage _cFeb 2016 |
||
| 300 |
_a315-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aActivin Receptors, Type II _xdrug effects |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aCartilage, Articular _xcytology |
| 650 | 0 | 4 |
_aCell Dedifferentiation _xdrug effects |
| 650 | 0 | 4 |
_aChondrocytes _xdrug effects |
| 650 | 0 | 4 |
_aCollagen Type X _xdrug effects |
| 650 | 0 | 4 |
_aCore Binding Factor Alpha 1 Subunit _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucocorticoids _xpharmacology |
| 650 | 0 | 4 |
_aGlycogen Synthase Kinase 3 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aLeptin _xmetabolism |
| 650 | 0 | 4 |
_aLymphotoxin-alpha _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 13 _xdrug effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsteoarthritis, Hip _xgenetics |
| 650 | 0 | 4 |
_aPrednisolone _xpharmacology |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xdrug effects |
| 650 | 0 | 4 |
_aRNA, Messenger _xdrug effects |
| 650 | 0 | 4 | _aReceptor, Transforming Growth Factor-beta Type I |
| 650 | 0 | 4 |
_aReceptors, Transforming Growth Factor beta _xdrug effects |
| 650 | 0 | 4 |
_aSOX9 Transcription Factor _xdrug effects |
| 650 | 0 | 4 |
_aSmad1 Protein _xdrug effects |
| 650 | 0 | 4 |
_aSmad2 Protein _xdrug effects |
| 650 | 0 | 4 |
_aSmad5 Protein _xdrug effects |
| 650 | 0 | 4 |
_aWnt Signaling Pathway _xdrug effects |
| 650 | 0 | 4 |
_abeta Catenin _xdrug effects |
| 700 | 1 | _aMalaise, O | |
| 700 | 1 | _aZeddou, M | |
| 700 | 1 | _aNeuville, S | |
| 700 | 1 | _aCobraiville, G | |
| 700 | 1 | _aDeroyer, C | |
| 700 | 1 | _aSanchez, C | |
| 700 | 1 | _aGillet, P | |
| 700 | 1 | _aKurth, W | |
| 700 | 1 | _ade Seny, D | |
| 700 | 1 | _aRelic, B | |
| 700 | 1 | _aMalaise, M G | |
| 773 | 0 |
_tOsteoarthritis and cartilage _gvol. 24 _gno. 2 _gp. 315-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.joca.2015.08.002 _zAvailable from publisher's website |
| 999 |
_c25212883 _d25212883 |
||